Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

NCT03585114 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03585114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 11, 2018
Completion date
December 31, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer